Incidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3+4 versus 4+3 prostate cancer

AIMS: The aim is to assess for a difference in the incidence of metastasis (IM) and prostate-specific antigen (PSA) levels at diagnosis in patients with Gleason score (GS) 3+4 versus 4+3 prostate cancer using a large veterans affairs database. SUBJECTS AND METHODS: A retrospective review of 1402 med...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamel, Mohamed H., Khalil, Mahmoud I., Alobuia, Wilson M., Su, Joseph, Davis, Rodney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907332/
https://www.ncbi.nlm.nih.gov/pubmed/29719335
http://dx.doi.org/10.4103/UA.UA_124_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907332/
https://www.ncbi.nlm.nih.gov/pubmed/29719335
http://dx.doi.org/10.4103/UA.UA_124_17

Ejemplares similares